Protective effects of a dual endothelin converting enzyme/neutral endopeptidase inhibitor on the development of pulmonary hypertension secondary to cardiac dysfunction in the rat

Pediatric Pulmonology
Zen-Kong DaiMian-Shin Tan

Abstract

Endothelium-derived nitric oxide (NO) and endothelin (ET)-1 interact to regulate the vascular tone in pulmonary hypertension (PH). We investigated the protective effects of an orally active, dual endothelin converting enzyme (ECE)/neutral endopeptidase (NEP) inhibitor/CGS 26393 on pulmonary vascular remodeling and pulmonary expressions of ET-1 and endothelial nitric oxide synthase (eNOS) during the development of PH secondary to cardiac dysfunction. Significant increases in the mean pulmonary arterial pressure, pulmonary arteriolar medial thickness, and pulmonary expression of ET-1 were seen in rats subjected to aortic banding for 4 weeks, compared with sham-operated rats. Treatment with CGS 26393 (30 mg/kg, twice daily, p.o.) began on 1 day after aortic banding. CGS 26393 treated rats had lower mean pulmonary arterial pressure (15 ± 1 mmHg, mean ± SEM, P < 0.05) compared to vehicle-treated rats (37 ± 1 mmHg). It also normalized pulmonary arteriolar medial thickness and reduced the levels of pulmonary ET-1 and big ET-1 by 55% (P < 0.05) and 28% (P < 0.01), respectively, when compared with vehicle-treated animals. Meanwhile, the expressions of eNOS mRNA and eNOS protein and cGMP levels in the lung of CGS 26393-treated rats were ...Continue Reading

References

Dec 1, 1995·British Journal of Clinical Pharmacology·R I Cargill, B J Lipworth
Mar 6, 1997·Biochemical and Biophysical Research Communications·J H KimG S Lee
Feb 10, 1999·The American Journal of Physiology·R C TylerI F McMurtry
Aug 3, 2000·American Journal of Physiology. Heart and Circulatory Physiology·E ThorinJ Dupuis
Feb 27, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·A J TurnerD Coates
Dec 14, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·Laurent StormeSteven H Abman
Mar 28, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
Mar 8, 2003·Hypertension·Duncan John Campbell
Jun 27, 2003·Journal of Cardiovascular Pharmacology·Daiji IsakaMasafumi Matsuo
Nov 9, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Stephen Wedgwood, Stephen M Black
Jun 21, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Philippe DeruelleSteven H Abman
Aug 24, 2005·Journal of Cardiovascular Pharmacology·Virginie MellinPaul Mulder
Jul 5, 2008·International Journal of Cardiology·Astrid E LammersSheila G Haworth
Jul 16, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jason GienSteven H Abman
Nov 18, 2008·Pharmacology & Therapeutics·Christopher J RhodesMartin R Wilkins

❮ Previous
Next ❯

Citations

Jun 10, 2011·Current Opinion in Cardiology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.